Development and Optimization of Mirabegron of Solid Lipid Nanoparticles as an Oral Delivery for Overactive Bladder.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutical nanotechnology"
DOI: 10.2174/2211738509666210127143107
Abstract: BACKGROUND Mirabegron (MBN), a β-3 adrenergic agent, is used in the treatment of overactive bladder. MBN has alow water solubility, high first-pass metabolism, and low bioavailability, consequently, having poor absorption in the gastrointestinal tract. OBJECTIVE… read more here.
Keywords: peg sln; mbn peg; bioavailability; mirabegron ... See more keywords